ISSUE 2 : FEBRUARY 2019

The Veeda Newsletter

Financials

TPG GROWTH TO POUR $30 MILLION IN INDIAN DRUG MAKER SOLARA ACTIVE

Renowned private equity firm, TPG Growth has recently announced plans to invest $30 million in Chennai-based active pharmaceutical ingredients (API) manufacturer, Solara Active Pharma.
Read more : http://healthcareopportunity.org/tpg-growth-to-pour-30-million-in-indian-drug-maker-solara-active/

Express Scripts Saved Plans $45 Billion on Prescription Drugs in 2018

Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S.
Read more : https://www.statnews.com/2018/12/12/kaleo-evzio-overdose-antidote-generic/

Sun Pharma net profit rises four-fold to Rs 1241.1 crore in Q3FY19

Sun Pharmaceutical Industries, India's largest drug maker said its net profit jumped 286.1 percent to Rs 1,241.1 crore in the third quarter ended December 2018, beating analyst estimates by a wide margin, helped by a strong recovery of US generics business.
Read more : https://www.moneycontrol.com/news/business/companies/sun-pharma-net-profit-rises-four-fold-to-rs-1241-1-crore-in-q3fy19-3522661.html


Teva down as it reports lower sales and profit for 2018

Israel-based generics giant Teva Pharmaceutical Industries today posted 2018 financial results, showing
Read more : https://www.thepharmaletter.com/article/teva-down-as-it-reports-lower-sales-and-profit-for-2018


Bharat Biotech eyes largest rabies vaccine maker tag after GSK deal

Hyderabad-based vaccine company Bharat Biotech's co-founder Krishna Ella, the scientist-turned entrepreneur, harbours hopes of making a major dent in the Indian and global vaccine space.
Read more : https://www.businesstoday.in/sectors/pharma/bharat-biotech-eyes-largest-rabies-vaccine-maker-tag-after-gsk-deal/story/319599.html

www.veedacr.com
info@veedacr.com
Contact Us